Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-57473
Nat Commun January 1, 2020; 11 (1): 5357.

Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains.

Kim J , Han W , Park T , Kim EJ , Bang I , Lee HS , Jeong Y , Roh K , Kim J , Kim JS , Kang C , Seok C , Han JK , Choi HJ .


Abstract
Low-density lipoprotein receptor-related protein 6 (LRP6) is a coreceptor of the β-catenin-dependent Wnt signaling pathway. The LRP6 ectodomain binds Wnt proteins, as well as Wnt inhibitors such as sclerostin (SOST), which negatively regulates Wnt signaling in osteocytes. Although LRP6 ectodomain 1 (E1) is known to interact with SOST, several unresolved questions remain, such as the reason why SOST binds to LRP6 E1E2 with higher affinity than to the E1 domain alone. Here, we present the crystal structure of the LRP6 E1E2-SOST complex with two interaction sites in tandem. The unexpected additional binding site was identified between the C-terminus of SOST and the LRP6 E2 domain. This interaction was confirmed by in vitro binding and cell-based signaling assays. Its functional significance was further demonstrated in vivo using Xenopus laevis embryos. Our results provide insights into the inhibitory mechanism of SOST on Wnt signaling.

PubMed ID: 33097721
PMC ID: PMC7585440
Article link: Nat Commun


Genes referenced: dkk1 egf ldlr lrp6 nodal sia1 wnt1 wnt2 wnt3a wnt9b
GO keywords: Wnt signaling pathway [+]


Article Images: [+] show captions
References [+] :
Afonine, Towards automated crystallographic structure refinement with phenix.refine. 2012, Pubmed